Abstract

One in three Americans experience medical cost distress, and more fear the cost of a serious illness more than getting seriously ill [1]. Individuals vulnerable to financial burden may decline care or take on debt, intensifying cost distress. Advanced imaging remains one of the most frequently ordered diagnostic tests, yet the financial burden associated with advanced imaging is rarely evaluated. Furthermore, identification of patients suffering from medically induced financial burden, regardless of the source of burden, is further hampered by heterogeneously implemented routine screening for financial fragility at the health system level.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.